Log in
Enquire now
Glycomine

Glycomine

Glycosylation corrective therapy

OverviewStructured DataIssuesContributors

Contents

glycomine.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Location
San Francisco
San Francisco
San Carlos, California
San Carlos, California
0
B2X
B2B
B2B
0
CEO
‌
Steven Axon
0
Pitchbook URL
pitchbook.com/profiles...123277-69
Number of Employees (Ranges)
1 – 10
Email Address
info@glycomine.com0
Phone Number
+165026475600
+14146613146
Full Address
733 Industrial Road San Carlos, CA 940700
Investors
Asahi Kasei
Asahi Kasei
Sanofi Genzyme
Sanofi Genzyme
0
Sanderling Ventures
Sanderling Ventures
Mesa Verde Venture Partners
Mesa Verde Venture Partners
0
Novo Holdings A/S
Novo Holdings A/S
Total Funding Amount (USD)
146,000,000
Latest Funding Round Date
June 23, 2021
Former CEO
Peter McWilliams
Peter McWilliams
0
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Contact Page URL
glycomine.com/contact/
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Glycomine

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.